|
Market Closed -
Nasdaq Stockholm
17:00:00 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 55.10 SEK | +3.47% |
|
-3.25% | -30.03% |
| 10:22am | Voleon Capital no longer a disclosed short seller in Smart Eye | FW |
| 09-08 | Espiria Sweden Small Cap rose 1.1% in August, positive contributions from Hansa Biopharma, Sinch and Paxman | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- SEYE Stock
- Consensus Smart Eye AB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
